+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States (US) Biotechnology Market Summary, Competitive Analysis and Forecast to 2027

  • PDF Icon

    Report

  • 49 Pages
  • September 2023
  • Region: United States
  • MarketLine
  • ID: 5694027
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
  • The US biotechnology market had total revenues of $395.3 billion in 2022, representing a compound annual growth rate (CAGR) of 17.2% between 2017 and 2022.
  • Medical/healthcare segment accounted for market's the largest proportion in 2022, with total revenues of $277.8 billion, equivalent to 70.3% of the market's overall value.
  • The US biotechnology market witnessed a strong growth of 14.3% in 2022. The U.S. biotech industry continues to grow significantly as venture finance, private equity, and initial public offerings (IPOs) support R&D and expansion.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts

Reasons to Buy

  • What was the size of the United States biotechnology market by value in 2022?
  • What will be the size of the United States biotechnology market in 2027?
  • What factors are affecting the strength of competition in the United States biotechnology market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the United States's biotechnology market?

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Has there been any recent M&A activity in the market?
8 Company Profiles
8.1. Johnson & Johnson
8.2. AbbVie Inc.
8.3. Amgen, Inc.
8.4. Biogen, Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related Research
10.4. About the Publisher
List of Tables
Table 1: United States biotechnology industry value: $ billion, 2017-22
Table 2: United States biotechnology industry category segmentation: % share, by value, 2017-2022
Table 3: United States biotechnology industry category segmentation: $ billion, 2017-2022
Table 4: United States biotechnology industry geography segmentation: $ billion, 2022
Table 5: United States biotechnology industry value forecast: $ billion, 2022-27
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: AbbVie Inc.: key facts
Table 11: AbbVie Inc.: Annual Financial Ratios
Table 12: AbbVie Inc.: Key Employees
Table 13: AbbVie Inc.: Key Employees Continued
Table 14: Amgen, Inc.: key facts
Table 15: Amgen, Inc.: Annual Financial Ratios
Table 16: Amgen, Inc.: Key Employees
Table 17: Amgen, Inc.: Key Employees Continued
Table 18: Biogen, Inc.: key facts
Table 19: Biogen, Inc.: Annual Financial Ratios
Table 20: Biogen, Inc.: Key Employees
Table 21: Biogen, Inc.: Key Employees Continued
Table 22: United States size of population (million), 2018-22
Table 23: United States gdp (constant 2005 prices, $ billion), 2018-22
Table 24: United States gdp (current prices, $ billion), 2018-22
Table 25: United States inflation, 2018-22
Table 26: United States consumer price index (absolute), 2018-22
Table 27: United States exchange rate, 2018-22
List of Figures
Figure 1: United States biotechnology industry value: $ billion, 2017-22
Figure 2: United States biotechnology industry category segmentation: $ billion, 2017-2022
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2022
Figure 4: United States biotechnology industry value forecast: $ billion, 2022-27
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2022
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2022
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2022
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2022
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2022
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2022

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Johnson & Johnson
  • AbbVie Inc.
  • Amgen, Inc.
  • Biogen, Inc.